comparemela.com
Home
Live Updates
Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences : comparemela.com
Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences
/PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN; the "Company" or "Biohaven") announced today that it has entered into a definitive...
Related Keywords
United States
,
Japan
,
Americans
,
Michael Bozik
,
Irfan Qureshi
,
Jen Porcelli
,
Steven Dworetzky
,
Knopp Biosciences
,
Mike Beyer
,
Biohaven Neuroinnovation
,
Biohaven Pharmaceuticals
,
Exchange Commission On
,
Company Or Biohaven
,
World Health Organization
,
Sam Brown Inc
,
Exchange Commission
,
Company Annual Report On Form
,
Biohaven Pharmaceutical Holding Company Ltd
,
Bristol Myers Squibb
,
Channel Biosciences
,
Biohaven Pharmaceutical Holding Company
,
Chief Executive Officer
,
World Health
,
Vice President
,
Channel Bioscience
,
Biohaven Labs
,
New Drug Approval
,
Chief Scientific Officer
,
Private Securities Litigation Reform Act
,
Annual Report
,
Biohaven Pharmaceutical Ireland
,
Media Relations
,
Pharmaceutical Holding Company
,
comparemela.com © 2020. All Rights Reserved.